AMA Adds CPT Codes for Pediatric COVID-19 Vaccine Candidate

Oct. 27, 2021: Accepted a Category I code to report SARS-CoV-2 vaccine and immunization administration codes. Code 0034A will be used to report Janssen booster vaccine and immunization administration. Appendix Q has been updated to reflect this addition. This code was published on Oct. 27, 2021 and was effective Oct. 20, 2021.

Oct. 6, 2021: Accepted three Category I codes to report SARS-CoV-2 vaccine and immunization administration codes. Codes 91307, 0071A, and 0072A are used to report Pfizer COVID-19 vaccine and immunization administration for the tris-sucrose pediatric (i.e., 5 through 11 years of age) dosage formulation. These codes were published on Oct. 6, 2021 and will be effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration.

Sept. 3, 2021: Accepted eight Category I codes to report SARS-CoV-2 vaccine and immunization administration codes. Codes 91305, 0051A, 0052A and 0053A are used to report Pfizer COVID-19 vaccine and immunization administration for the tris-sucrose formulation. Codes 0004A and 0054A are used to report Pfizer COVID-19 immunization administration booster doses for both available formulations. Codes 91306 and 0064A are used to report Moderna COVID-19 vaccine and immunization administration booster doses. Appendix Q has been updated to reflect these additions. These codes were published on Sept. 3, 2021 and will be effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration.

Source: https://www.ama-assn.org/practice-management/cpt/covid-19-cpt-coding-and-guidance